These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8814331)

  • 21. Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies.
    Lavabre-Bertrand T; Exbrayat C; Liautard J; Gaillard JP; Baskevitch PP; Poujol N; Duperray C; Bourquard P; Brochier J
    Br J Haematol; 1995 Dec; 91(4):871-7. PubMed ID: 8547132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.
    Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G
    EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha).
    März P; Gadient RA; Otten U
    Brain Res; 1996 Jan; 706(1):71-9. PubMed ID: 8720493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemical study.
    Taniguchi Y; Yorioka N; Oda H; Yamakido M
    Nephron; 1996; 74(4):652-60. PubMed ID: 8956297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a soluble IL-6 receptor alpha mutant C277D/H280I expressed in E.coli.
    Duan J; Wang J; Cai X; Wang L; Liu H; Zou M
    Biochem Mol Biol Int; 1997 May; 41(6):1101-8. PubMed ID: 9161704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing therapeutic strategies to inhibit circulating soluble target molecules with monoclonal antibodies: example of the soluble IL-6 receptors.
    Brochier J; Liautard J; Jacquet C; Gaillard JP; Klein B
    Eur J Immunol; 2001 Jan; 31(1):259-64. PubMed ID: 11265642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-6-type cytokines and their receptors for gene therapy of melanoma.
    Mackiewicz A; Wiznerowicz M; Roeb E; Nowak J; Pawlowski T; Baumann H; Heinrich PC; Rose-John S
    Ann N Y Acad Sci; 1995 Jul; 762():361-73; discussion 373-4. PubMed ID: 7668537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma.
    Campo S; Serlupi-Crescenzi O; Arseni B; Rossi S; Saggio I; Salone B; Cherubini G; Carminati P; De Santis R
    Cytokine; 2005 Sep; 31(5):368-74. PubMed ID: 16061391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.
    Rozemuller H; Rombouts WJ; Touw IP; FitzGerald DJ; Kreitman RJ; Pastan I; Hagenbeek A; Martens AC
    Leukemia; 1996 Nov; 10(11):1796-803. PubMed ID: 8892684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA.
    Oh JW; Revel M; Chebath J
    Cytokine; 1996 May; 8(5):401-9. PubMed ID: 8726669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells.
    Sui X; Tsuji K; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Ikebuchi K; Yasukawa K; Taga T; Kishimoto T
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2859-63. PubMed ID: 7535932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
    Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
    Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
    Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
    Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors.
    Udagawa N; Takahashi N; Katagiri T; Tamura T; Wada S; Findlay DM; Martin TJ; Hirota H; Taga T; Kishimoto T; Suda T
    J Exp Med; 1995 Nov; 182(5):1461-8. PubMed ID: 7595216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat.
    Shizuya K; Komori T; Fujiwara R; Miyahara S; Ohmori M; Nomura J
    Life Sci; 1997; 61(10):PL 135-40. PubMed ID: 9296342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion.
    Fischer M; Goldschmitt J; Peschel C; Brakenhoff JP; Kallen KJ; Wollmer A; Grötzinger J; Rose-John S
    Nat Biotechnol; 1997 Feb; 15(2):142-5. PubMed ID: 9035138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta.
    Vallières L; Rivest S
    J Neurochem; 1997 Oct; 69(4):1668-83. PubMed ID: 9326296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning, expression and purification of the ligand-binding region of human IL-6R in E. coli and its preliminary functional identification.
    Duan J; Wang J; Han J; Peng S; Zou M; Miao J; Zhao C; Ma X
    Sci China B; 1995 Nov; 38(11):1321-31. PubMed ID: 8745530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
    Toren A; Novick D; Or R; Ackerstein A; Slavin S; Nagler A
    Transplantation; 1996 Jul; 62(1):138-42. PubMed ID: 8693533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
    Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y
    Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.